login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NOVO-NORDISK A/S-SPONS ADR (NVO) Stock News
USA
- NYSE:NVO -
US6701002056
-
ADR
59.635
USD
+0.61 (+1.04%)
Last: 10/8/2025, 12:55:10 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NVO Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Chartmill
Novo Nordisk (NYSE:NVO) Presents a Compelling Case for Value Investors
18 days ago - By: Chartmill
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) Emerges as a Top Affordable Growth Stock
a day ago - By: Benzinga
Wegovy, Ozempic Maker Novo Nordisk Cuts Staff At Key US Production Sites
a day ago - By: The Motley Fool
- Mentions:
LLY
Where Will LLY Be in 5 Years?
a day ago - By: Stocktwits
- Mentions:
AVDE
PID
Novo Nordisk Reportedly Slashes Workforce At Its US Wegovy Manufacturing Plant
2 days ago - By: Benzinga
- Mentions:
SKYE
Skye Bioscience's Investigational Drug Disappoints As Monotherapy For Weight Loss
3 days ago - By: The Motley Fool
- Mentions:
VRTX
LLY
2 Beaten-Down Stocks Primed for a Comeback
6 days ago - By: Zacks Investment Research
- Mentions:
BMY
MRK
Can Novo Nordisk's Restructuring Program Drive its Return to Growth?
7 days ago - By: Levi & Korsinsky, LLP
Class Action Filed Against Novo Nordisk A/S (NVO) Seeking Recovery for Investors - Contact Levi & Korsinsky
7 days ago - By: Stocktwits
Novo Nordisk Retail Traders Stay Bullish Despite Brutal 2025 — Analysts Flag A Key Catalyst That Can Turn Things Around
8 days ago - By: Zacks Investment Research
- Mentions:
LLY
VKTX
Can NVO Maintain Obesity Leadership With Next-Generation Candidates?
8 days ago - By: Faruqi & Faruqi, LLP
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
8 days ago - By: Investor's Business Daily
- Mentions:
LLY
BMY
Trump's Plan To Lower U.S. Drug Prices Faces Big Test
8 days ago - By: Zacks Investment Research
Why Novo Nordisk (NVO) is a Top Growth Stock for the Long-Term
8 days ago - By: Stocktwits
- Mentions:
LFMD
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients
9 days ago - By: THE ROSEN LAW FIRM, P. A.
NVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
9 days ago - By: The Law Offices of Frank R. Cruz
Deadline Soon: Novo Nordisk A/S (NVO) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
9 days ago - By: Bragar Eagel & Squire
NOVO URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30th
9 days ago - By: The Gross Law Firm
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NVO
9 days ago - By: Stocktwits
- Mentions:
OZEM
JAVA
Why Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket Today
10 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
12 days ago - By: DJS Law Group
Novo Nordisk A/S Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NVO
12 days ago - By: Bragar Eagel & Squire
NOVO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30th
12 days ago - By: Levi & Korsinsky, LLP
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights - NVO
12 days ago - By: Berger Montague
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Novo Nordisk A/S (NYSE: NVO) Investors to Inquire About a Securities Fraud Class Action by September 30, 2025
Please enable JavaScript to continue using this application.